Research Article
Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The “Opt-Out” Process
Table 4
Genetic testing outcomes.
| ||||||||||||||||||||||||||||||||||||||
NGS: next generation sequencing; VUS: variant of uncertain significance. 125 patients had undergone genetic testing during January 2015–December 2017. Results of the genetic tests were known for 123 patients, while results were pending for 2 patients. Non-BRCA pathogenic variants detected: BRIP1, MUTYH heterozygote, PALB2, RAD51C, and TP53(mos). Some patients had more than one VUS in multiple genes. |